Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective: Although clinical hyperthyroidism (HR) is associated with insulin resistance, the information on insulin action in subclinical hyperthyroidism (SHR) is limited. Design and methods: To investigate this, we assessed the sensitivity of glucose metabolism to insulin in vivo(by an oral glucose tolerance test) and in vitro(by measuring insulin-stimulated rates of glucose transport in isolated monocytes) in 12 euthyroid subjects (EU), 16 patients with HR, and 10 patients with SHR. Results: HR and SHR patients displayed higher postprandial glucose levels (area under the curve, AUC 0–300 32 190±1067 and 31 497±716 mg/dl min respectively) versus EU (27 119±1156 mg/dl min,P<0.05). HR but not SHR patients displayed higher postprandial insulin levels (AUC 0–300 11 020±985 and 9565±904 mU/l min respectively) compared with EU subjects (AUC 0–300 7588±743 mU/l min,P<0.05). Homeostasis model assessment index was increased in HR and SHR patients (2.81±0.3 and 2.43±0.38 respectively) compared with EU subjects (1.27±0.16,P<0.05), while Matsuda and Belfiore indices were decreased in HR (4.21±0.41 and 0.77±0.05 respectively,P<0.001) and SHR patients (4.47±0.33 and 0.85±0.05 respectively,P<0.05 versus EU (7.76±0.87 and 1 respectively). At 100 μU/ml insulin, i) GLUT3 levels on the monocyte plasma membrane were increased in HR (468.8±7 mean fluorescence intensity (MFI)) and SHR patients (522.2±25 MFI) compared with EU subjects (407±18 MFI,P<0.01 and P<0.05 respectively), ii) glucose transport rates in monocytes (increases from baseline) were decreased in HR patients (37.8±5%) versus EU subjects (61.26±10%,P<0.05). Conclusions: Insulin-stimulated glucose transport in isolated monocytes of patients with HR was decreased compared with EU subjects. Insulin resistance was comparable in patients with both HR and SHR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Glucose Transporters and Insulin Action — Implications for Insulin Resistance and Diabetes Mellitus
Shepherd, P. R., & Kahn, B. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410406 · Cited by 1,295
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229
Subclinical hyperthyroidism: clinical features and treatment options
Biondi, B., Palmieri, E. A., Klain, M., Schlumberger, M., Filetti, S., & Lombardi, G. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01809 · Cited by 217
Thyroid hormone excess and glucose intolerance
Dimitriadis, G., & Raptis, S. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18584 · Cited by 179
Self-citationHeemstra, K. A., Smit, J. W. A., Eustatia‐Rutten, C. F. A., Heijboer, A. C., Frölich, M., Romijn, J. A., & Corssmit, E. P. M. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02660.x · Cited by 31
Dimitriadis, G., Maratou, E., Alevizaki, M., Boutati, E., Psara, K., Papasteriades, C., & Raptis, S. A. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-861026 · Cited by 28
Self-citation
Cited by
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“and decreased insulin sensitivity in SH, suggesting this may contribute to increased cardiovascular risk (397,398).”
BackgroundThyroid dysfunction and diabetes mellitus: two closely associated disorders
Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00163 · Cited by 598
The relationship between type 2 diabetes mellitus and related thyroid diseases
Wang, C. (2013) · Journal of Diabetes Research · doi:10.1155/2013/390534 · Cited by 273
Bruinstroop, E., Dalan, R., Cao, Y., Bee, Y. M., Chandran, K., Cho, L. W., Soh, S. B., Teo, E. K., Toh, S.-A., Leow, M. K. S., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00475 · Cited by 108
A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes
Alghamdi, F., Guo, M., Abdulkhalek, S., Crawford, N., Amith, S. R., & Szewczuk, M. R. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.02.015 · Cited by 87
Metadata
- Authors
- Maratou, E., Hadjidakis, D. J., Peppa, M., Alevizaki, M., Tsegka, K., Lambadiari, V., Mitrou, P., Boutati, E., Kollias, A., Economopoulos, T., Raptis, S. A., & Dimitriadis, G.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10
- Volume
- 163
- Issue
- 4
- Pages
- 625-630
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W4242702777
- Cited by
- 112
- References
- 7
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. https://app.cochat.ai/papers/10.1530/eje-10-0246
- The paper
- Maratou, E., Hadjidakis, D. J., Peppa, M., Alevizaki, M., Tsegka, K., Lambadiari, V., Mitrou, P., Boutati, E., Kollias, A., Economopoulos, T., Raptis, S. A., & Dimitriadis, G. (2010). Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. European Journal of Endocrinology. https://doi.org/10.1530/eje-10-0246
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.